Citadel Advisors
LENZ

Citadel Advisors’s LENZ Therapeutics LENZ Stock Holding History

Citadel Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-80,574
Closed -$1.13M – 14458
2025
Q4 		$1.29M Sell
80,574
-318,856
-80% -$9.29M ﹤0.01% 6849
2025
Q3 		$18.6M Buy
399,430
+390,393
+4,320% +$14.4M ﹤0.01% 2426
2025
Q2 		$265K Sell
9,037
-557
-6% -$15.2K ﹤0.01% 10087
2025
Q1 		$247K Buy
+9,594
New +$236K ﹤0.01% 10017
2024
Q1 		– Sell
-83,818
Closed -$1.54M – 15566
2023
Q4 		$1.54M Sell
83,818
-93,676
-53% -$1.55M ﹤0.01% 5839
2023
Q3 		$3.08M Buy
177,494
+5,452
+3% +$94.8K ﹤0.01% 4428
2023
Q2 		$3.13M Buy
172,042
+4,731
+3% +$94.5K ﹤0.01% 4390
2023
Q1 		$2.87M Sell
167,311
-2,748
-2% -$44.4K ﹤0.01% 4713
2022
Q4 		$3.95M Sell
170,059
-11,948
-7% -$277K ﹤0.01% 4260
2022
Q3 		$4.04M Sell
182,007
-6,541
-3% -$156K ﹤0.01% 4238
2022
Q2 		$3.63M Buy
188,548
+9,306
+5% +$207K ﹤0.01% 4407
2022
Q1 		$6.4M Buy
179,242
+1,345
+0.8% +$84.1K ﹤0.01% 3709
2021
Q4 		$15.5M Sell
177,897
-3,556
-2% -$295K ﹤0.01% 2367
2021
Q3 		$20.5M Sell
181,453
-2,579
-1% -$382K ﹤0.01% 1959
2021
Q2 		$38.9M Buy
+184,032
New +$32.1M 0.01% 1339

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Citadel Advisors's LENZ Position: Q1 2026 in Review

Citadel Advisors sold out of LENZ Therapeutics (LENZ) in Q1 2026, closing a stake of 80,574 shares — an estimated $1.13M sold.

Citadel Advisors first reported a position in LENZ in Q2 2021 and held it in 15 quarters. The position peaked at $38.9M in Q2 2021. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Citadel Advisors reported no remaining LENZ Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 80,574 LENZ Therapeutics shares in Q1 2026, an estimated $1.13M.
  • Citadel Advisors first reported a position in LENZ Therapeutics in Q2 2021 and held it in 15 quarters.
  • Citadel Advisors's LENZ Therapeutics position peaked at $38.9M in Q2 2021.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.